Vol. 65 No. 3 (2011), Others
Vol. 65 No. 3 (2011)

Which non-steroidal anti-inflammatory drug should be used in patients with increased risk of gastrointestinal toxicity?

Others
Published 13. 10. 2014
Martin Bortlík
IBD clinical and research centre ISCARE a.s., Prague, Czech Republic; Department of Internal Medicine, 1st Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic; Institute of Pharmacology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
Milan Lukáš
IBD clinical and research centre ISCARE a.s., Prague, Czech Republic
PDF

Keywords

antiflogistika nesteroidní
duodenum
gastrointestinální nemoci
hodnocení léčiv
kombinovaná farmakoterapie
lidé
stomach
výsledek terapie
diklofenak
dvanáctníkové vředy
inhibitory cyklooxygenázy 2
klinické zkoušky jako téma
omeprazol
žaludeční vředy